89 related articles for article (PubMed ID: 31053301)
1. Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation.
Haryuni RD; Watabe S; Yamaguchi A; Fukushi Y; Tanaka T; Kawasaki Y; Zhou Y; Yokoyama S; Sakurai H
Biochem Biophys Res Commun; 2019 Jun; 514(2):456-461. PubMed ID: 31053301
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
3. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.
Zeng F; Zhang MZ; Singh AB; Zent R; Harris RC
Mol Biol Cell; 2007 Nov; 18(11):4446-56. PubMed ID: 17761534
[TBL] [Abstract][Full Text] [Related]
4. Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain.
Kawasaki Y; Sakimura A; Park CM; Tomaru R; Tanaka T; Ozawa T; Zhou Y; Narita K; Kishi H; Muraguchi A; Sakurai H
Sci Rep; 2016 Aug; 6():31502. PubMed ID: 27531070
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the four isoforms of receptor tyrosine kinase ErbB4, but not ErbB1, confers cardiomyocyte hypertrophy.
Wang Z; Chan HW; Gambarotta G; Smith NJ; Purdue BW; Pennisi DJ; Porrello ER; O'Brien SL; Reichelt ME; Thomas WG; Paravicini TM
J Cell Physiol; 2021 Dec; 236(12):8160-8170. PubMed ID: 34170016
[TBL] [Abstract][Full Text] [Related]
6. Cell death or survival promoted by alternative isoforms of ErbB4.
Sundvall M; Veikkolainen V; Kurppa K; Salah Z; Tvorogov D; van Zoelen EJ; Aqeilan R; Elenius K
Mol Biol Cell; 2010 Dec; 21(23):4275-86. PubMed ID: 20943952
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.
Chen CH; Hsia TC; Yeh MH; Chen TW; Chen YJ; Chen JT; Wei YL; Tu CY; Huang WC
Mol Oncol; 2017 Sep; 11(9):1273-1287. PubMed ID: 28632938
[TBL] [Abstract][Full Text] [Related]
8. Activating ERBB4 mutations in non-small cell lung cancer.
Kurppa KJ; Denessiouk K; Johnson MS; Elenius K
Oncogene; 2016 Mar; 35(10):1283-91. PubMed ID: 26050618
[TBL] [Abstract][Full Text] [Related]
9. ErbB4 cleavage by gonadotropin-releasing hormone receptor stimulation in cultured gonadotroph cells.
Omoto Y; Higa-Nakamine S; Higa A; Yamamoto H
Eur J Pharmacol; 2017 Mar; 799():171-179. PubMed ID: 28167260
[TBL] [Abstract][Full Text] [Related]
10. An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation.
Vaparanta K; Jokilammi A; Tamirat M; Merilahti JAM; Salokas K; Varjosalo M; Ivaska J; Johnson MS; Elenius K
Nat Commun; 2022 Nov; 13(1):6953. PubMed ID: 36376313
[TBL] [Abstract][Full Text] [Related]
11. High glucose forces a positive feedback loop connecting ErbB4 expression and mTOR/S6K pathway to aggravate the formation of tau hyperphosphorylation in differentiated SH-SY5Y cells.
Nie SD; Li X; Tang CE; Min FY; Shi XJ; Wu LY; Zhou SL; Chen Z; Wu J; Song T; Dai ZJ; Zheng J; Liu JJ; Wang S
Neurobiol Aging; 2018 Jul; 67():171-180. PubMed ID: 29674181
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
Elenius K; Choi CJ; Paul S; Santiestevan E; Nishi E; Klagsbrun M
Oncogene; 1999 Apr; 18(16):2607-15. PubMed ID: 10353604
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase.
Knittle AM; Helkkula M; Johnson MS; Sundvall M; Elenius K
J Biol Chem; 2017 Dec; 292(48):19890-19904. PubMed ID: 28974580
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between Thr-669 and constitutive tyrosine phosphorylation in the asymmetric epidermal growth factor receptor dimer conformation.
Sato K; Shin MS; Sakimura A; Zhou Y; Tanaka T; Kawanishi M; Kawasaki Y; Yokoyama S; Koizumi K; Saiki I; Sakurai H
Cancer Sci; 2013 Oct; 104(10):1315-22. PubMed ID: 23822636
[TBL] [Abstract][Full Text] [Related]
16. ErbB4-mediated regulation of vasculogenic mimicry capability in breast cancer cells.
Kawahara R; Simizu S
Cancer Sci; 2022 Mar; 113(3):950-959. PubMed ID: 34971015
[TBL] [Abstract][Full Text] [Related]
17. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
Thiel KW; Carpenter G
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain.
Tan W; Dean M; Law AJ
PLoS One; 2010 Sep; 5(9):e12924. PubMed ID: 20886074
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
Yumoto N; Yu X; Hatakeyama M
Mol Cell Biochem; 2006 Apr; 285(1-2):165-71. PubMed ID: 16477370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
